IP Library › Assignment 019341/0642
Patent Assignment
Reel/Frame 019341/0642

Change of Name

Recorded: 2007-05-29 Received: 2007-05-29 Pages: 11
Assignor
DAIICHI ASUBIO PHARMA CO., LTD.
Executed: 2007-04-02
Assignee
ASUBIO PHARMA CO., LTD.
9-11, AKASAKA 2-CHOME, MINATO-KU, TOKYO, JPX, JAPAN
Covered Properties (19)
Quinazoline Derivatives and Pharmaceutical Applications Thereof
Application: 11/073,654 →
Method for Producing a Modified Peptide
Application: 10/500,018 →
Process for Producing (Dioxolenon-4-Yl)Methyl Ester Derivative
Application: 10/473,297 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Application: 10/615,836 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Application: 10/421,929 →
Aminophenoxyacetic Acid Derivatives and Pharmaceutical Composition Containing Thereof
Application: 10/394,221 →
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Application: 10/331,508 →
A Pharmaceutical Component Based on Human Parathyroid Hormone and a Pharmaceutical Composition for Intranasal Administration Comprising the Component
Application: 10/312,726 →
Arylpiperidinol and Arylpiperidine Derivatives and Pharmaceuticals Containing the Same
Application: 10/196,362 →
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Application: 10/118,045 →
Aminophenoxyacetamide Derivatives and Pharmaceutical Composition Containing Thereof
Application: 10/009,566 →
A Chymase Inhibitor for the Treatment of Eosinophilia
Application: 09/959,358 →
Preventive or Therapeutic Drugs for Fibrosis Containing Chymase Inhibitors as the Active Ingredient
Application: 09/959,232 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Application: 09/939,829 →
Coupling Factor 6 Inhibitor and Potentiator and Use Thereof
Application: 09/831,951 →
Blood Vessel Lipid Deposition-Preventive Agent Comprising Chymase-Inhibitor
Application: 09/869,360 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Application: 09/871,655 →
Quinazoline Derivatives and Pharmaceutical Applications Therof
Application: 09/763,213 →
Treatment or Prophylaxis of Ischemic Heart Disease
Application: 09/752,724 →